Ignite Creation Date:
2024-05-06 @ 9:15 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02942342
Status:
UNKNOWN
Last Update Posted:
2020-09-01
First Post:
2016-03-31
Brief Title:
Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo MI
Sponsor:
Borgess Research Institute
Organization:
Borgess Research Institute
Study Overview
Official Title:
Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo County and Neighboring Areas in Michigan Who Have Risk Factors of Coronary Artery Disease
Status:
UNKNOWN
Status Verified Date:
2020-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ESCAPE MI
Brief Summary:
The primary goal of this study is to determine the prevalence of undiagnosed asymptomatic coronary artery disease CAD in Kalamazoo and its neighboring areas using Coronary Computed Tomography CCTA and Coronary Artery Calcium Score CACS to assess if asymptomatic CAD is widespread enough to warrant implementation of CCTA as a routine screening tool Additionally this study will use the CCTA results to evaluate several methods of assessing CAD risk in the asymptomatic population including Framingham Risk Score FRS and Reynolds Risk Score Biomarkers High sensitivity C-Reactive Protein Fibrinogen Vertical Auto Profile oxidized Low Density Lipoprotein LDL Apolipoprotein A1 ApoA1 Apolipoprotein B1 ApoB1 Vitamin D Homocysteine as well as a large panel of genetic markers of atherosclerosis and dyslipidemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None